Sign Up to like & get
recommendations!
0
Published in 2020 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2020.06.026
Abstract: ABSTRACT The timing of immunosuppressive therapy used in combination with post-transplantation cyclophosphamide (PTCY) in haploidentical hematopoietic stem cell transplant (haplo-HSCT) is not standardized. We evaluated the schedules of immunosuppression therapy after haplo-HSCT in 509 patients…
read more here.
Keywords:
post transplantation;
transplantation cyclophosphamide;
acute leukemia;
transplantation ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Seminars in hematology"
DOI: 10.1053/j.seminhematol.2018.09.002
Abstract: Allogeneic blood or marrow transplantation (BMT) is a curative therapy for a number of high-risk hematologic malignancies. Historically, only patients with a human leukocyte antigen (HLA)-matched sibling or unrelated donor were able to receive this…
read more here.
Keywords:
post transplantation;
transplantation cyclophosphamide;
cyclophosphamide facilitate;
transplantation ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms232315192
Abstract: Most cases of acquired aplastic anemia (AA) arise from autoimmune destruction of hematopoietic stem and progenitor cells. Human leukocyte antigen (HLA)-haploidentical nonmyeloablative hematopoietic stem cell transplantation (HSCT) plus post-transplantation cyclophosphamide (PTCy) is increasingly applied to…
read more here.
Keywords:
post transplantation;
acquired aplastic;
plus post;
transplantation cyclophosphamide ... See more keywords